Just saying that's how it begins, not claiming tim tams have magical properties of persuasion. Launching Cardiocel means spreading the word, increasing the number of surgical cases, and centres using Cardiocel. This has been proceeding very nicely.
There are always "amazing new products" to talk about. But surgeons like to see that others are using it successfully before they do. That's why having those figures of 1200 or 1600 procedures are so important, and will hopefully have a snowball effect on sales.
Regarding the product price, my understanding is AHZ could increase it significantly and it would still be highly affordable. There are many expenses involved in a CV surgery, and it sounds like the patch itself will remain a small part of that (even if it doubles or triples in price). Peace out -- hope for good news tomorrow
Review of recent months, page-35
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |